Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal vs Parenteral Ceftriaxone for SSI Prevention
NCT04975945Phase 4Withdrawn
- Sponsor
- Grant Medical College and Sir J.J. Group of Hospitals
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ceftriaxone in surgical site infection (SSI), sponsored by Grant Medical College and Sir J.J. Group of Hospitals. Planned start Aug 2021; status: withdrawn.
02
Drugs
ceftriaxone
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04975945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04975945.